Skyrizi

NORTH CHICAGO, Ill., May 5, 2026 AbbVie Inc. has presented extensive new data across its gastroenterology portfolio at the...

Montréal, 28 November 2025 In a major development for inflammatory bowel disease (IBD) care, Canada’s Drug Agency (AMC) has...

NORTH CHICAGO, Ill., November 2, 2025 — AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has raised its annual...